Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 1

Status

Active not recruiting 2Recruiting 1Completed 1

Sponsor Class

NIH 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Squamous Cell Carcinoma of Head and Neck 6Oropharyngeal Neoplasms 5Lung Neoplasms 5Mesothelioma, Malignant 4Carcinoma, Non-Small-Cell Lung 4Urinary Bladder Neoplasms 3Nasopharyngeal Carcinoma 3Mouth Neoplasms 3Laryngeal Neoplasms 3Carcinoma 3Uterine Cervical Neoplasms 2Pancreatic Neoplasms 2Lymphoid Interstitial Pneumonia 2Hypopharyngeal Neoplasms 2Ganglioneuroblastoma 2Cholangiocarcinoma 2Adenocarcinoma of Lung 2Wilms Tumor 1Vulvar Neoplasms 1Vaginal Neoplasms 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Solitary Fibrous Tumor, Pleural 1Small Cell Lung Carcinoma 1Sinonasal Squamous Cell Carcinoma 1Salivary Gland Neoplasms 1Resectable Intrahepatic Cholangiocarcinoma 1Renal Pelvis and Ureter Urothelial Carcinoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Osteosarcoma 1

Interventions

Carboplatin 52pembrolizumab 51Pemetrexed 44Cisplatin 35Paclitaxel 21Nivolumab 20Docetaxel 19durvalumab 17Gemcitabine 14130-nm albumin-bound paclitaxel 14osimertinib 13Cetuximab 12Specimen Handling 11Magnetic Resonance Spectroscopy 11atezolizumab 10amivantamab 8Taxes 7Radiotherapy 7lazertinib 6alectinib 6Ramucirumab 6Radiosurgery 6Observation 6Ipilimumab 6Bevacizumab 6cemiplimab 5Leucovorin 5Fluorouracil 5zimberelimab 4entrectinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Platinum × 30 days × Clear all
NCT04267848 2026-06-03

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

National Cancer Institute (NCI)

Phase 3 Recruiting
1,210 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02194738 2026-05-29

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

National Cancer Institute (NCI)

Phase NA Active not recruiting
8,300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04092283 2026-05-29

Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
660 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01993810 2026-05-27

Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
330 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡